Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth
Primary Purpose
Preterm Birth
Status
Withdrawn
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
TVU CL screening
Sponsored by

About this trial
This is an interventional screening trial for Preterm Birth
Eligibility Criteria
Inclusion Criteria:
- 18-50 years of age
- Singleton pregnancy (limits the participants to female gender)
- No prior spontaneous preterm delivery, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks
Exclusion Criteria:
- Multiple gestation
- Prior spontaneous preterm birth 16-36 6/7 weeks
- Ruptured membranes at time of randomization
- Lethal fetal structural anomaly at time of randomization
- Fetal chromosomal abnormality at time of randomization
- Placenta previa and/or accreta at time of randomization
- Women who already underwent TVU CL measurement during the index pregnancy
Sites / Locations
- Gabriele Saccone
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
TVU CL screening
no screening
Arm Description
TVU CL screening: single TVU CL at 18 0/7 to 23 6/7 every week
no TVU CL screening
Outcomes
Primary Outcome Measures
preterm birth rate
either spontaneous or indicated preterm delivery
Secondary Outcome Measures
Perinatal death
either neonatal death or fetal death
preterm birth rates
either spontaneous or indicated preterm delivery
admission to neonatal intensive care unit
Composite perinatal outcome
Includes necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death
necrotizing enterocolitis
Defined as modified Bell Stage 2 or 3. Stage 2: Clinical signs and symptoms with pneumatosis intestinalis on radiographs. Stage 3: Advanced clinical signs and symptoms, pneumatosis, impending or proven intestinal perforation
intraventricular hemorrhage (grade 3 or higher)
IVH
respiratory distress syndrome
Respiratory distress with an oxygen requirement and a chest x-ray that shows hypoaeration and reticulogranular infiltrates
birth weight
Length of hospital stay
Days in NICU
Neonatal death
gestational age at delivery
latency
from randomization to delivery
Full Information
NCT ID
NCT02928302
First Posted
October 6, 2016
Last Updated
November 15, 2018
Sponsor
Federico II University
1. Study Identification
Unique Protocol Identification Number
NCT02928302
Brief Title
Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth
Official Title
Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Withdrawn
Why Stopped
new protocol started 31/18
Study Start Date
July 23, 2018 (Actual)
Primary Completion Date
September 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federico II University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations.
However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, we aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy without prior spontaneous PTB
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth
7. Study Design
Primary Purpose
Screening
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
TVU CL screening
Arm Type
Experimental
Arm Description
TVU CL screening: single TVU CL at 18 0/7 to 23 6/7 every week
Arm Title
no screening
Arm Type
No Intervention
Arm Description
no TVU CL screening
Intervention Type
Other
Intervention Name(s)
TVU CL screening
Intervention Description
Transvaginal ultrasound cervical length screening
Primary Outcome Measure Information:
Title
preterm birth rate
Description
either spontaneous or indicated preterm delivery
Time Frame
Less than 37 weeks
Secondary Outcome Measure Information:
Title
Perinatal death
Description
either neonatal death or fetal death
Time Frame
Between birth and 28 days of age
Title
preterm birth rates
Description
either spontaneous or indicated preterm delivery
Time Frame
Less than 24, 28, 32, 30, and 34 weeks gestation
Title
admission to neonatal intensive care unit
Time Frame
time of delivery
Title
Composite perinatal outcome
Description
Includes necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death
Time Frame
Between birth and 28 days of age
Title
necrotizing enterocolitis
Description
Defined as modified Bell Stage 2 or 3. Stage 2: Clinical signs and symptoms with pneumatosis intestinalis on radiographs. Stage 3: Advanced clinical signs and symptoms, pneumatosis, impending or proven intestinal perforation
Time Frame
Between birth and 28 days of age
Title
intraventricular hemorrhage (grade 3 or higher)
Description
IVH
Time Frame
Between birth and 28 days of age
Title
respiratory distress syndrome
Description
Respiratory distress with an oxygen requirement and a chest x-ray that shows hypoaeration and reticulogranular infiltrates
Time Frame
Time of delivery
Title
birth weight
Time Frame
time of delivery
Title
Length of hospital stay
Description
Days in NICU
Time Frame
Discharge from hospital
Title
Neonatal death
Time Frame
Between birth and 28 days of age
Title
gestational age at delivery
Time Frame
time of delivery
Title
latency
Description
from randomization to delivery
Time Frame
time of delivery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18-50 years of age
Singleton pregnancy (limits the participants to female gender)
No prior spontaneous preterm delivery, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks
Exclusion Criteria:
Multiple gestation
Prior spontaneous preterm birth 16-36 6/7 weeks
Ruptured membranes at time of randomization
Lethal fetal structural anomaly at time of randomization
Fetal chromosomal abnormality at time of randomization
Placenta previa and/or accreta at time of randomization
Women who already underwent TVU CL measurement during the index pregnancy
Facility Information:
Facility Name
Gabriele Saccone
City
Naples
ZIP/Postal Code
80100
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth
We'll reach out to this number within 24 hrs